BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7688266)

  • 41. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.
    Buechler C; Ritter M; Orsó E; Langmann T; Klucken J; Schmitz G
    J Leukoc Biol; 2000 Jan; 67(1):97-103. PubMed ID: 10648003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B; Camus S; Yagello M; Gluckman JC
    Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour necrosis factor alpha production by polymorphonuclear neutrophils treated with mouse anti-human CD19 monoclonal antibody.
    Nishimura M
    Cell Biochem Funct; 2004; 22(4):207-11. PubMed ID: 15248179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.
    Young MR; Wright MA; Matthews JP; Malik I; Prechel M
    J Immunol; 1996 Mar; 156(5):1916-22. PubMed ID: 8596044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of interleukin-1 in the differentiation-inducing activity of tumor necrosis factor-alpha on a murine myeloid leukemia (WEHI-3B JCS).
    Chan S; Fung M; Mak N; Leung K
    Int J Oncol; 1997 Apr; 10(4):821-6. PubMed ID: 21533451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Induction of differentiation of myelomonocytic leukemia cells by mitoxantrone].
    Kajigaya Y; Takahashi H; Sekiguchi H; Okuyama T; Ikuta K; Sasaki H; Kanaya A; Matsuyama S
    Rinsho Ketsueki; 1990 Oct; 31(10):1633-9. PubMed ID: 2255055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of differentiation of WEHI-3B D+ leukemic cells transfected with differentiation-stimulating factor/leukemia inhibitory factor receptor cDNA.
    Tomida M
    Blood; 1995 Jan; 85(1):217-21. PubMed ID: 7528568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia.
    Smith C; Muench MO; Knizewski M; Gilboa E; Moore MA
    Leukemia; 1993 Feb; 7(2):310-7. PubMed ID: 8426483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cell differentiation action of 4'-epi-adriamycin in WEHI-3B myelomonocytic leukemia cells].
    Kajigaya Y; Ikuta K; Sasaki H; Matsuyama S
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2409-15. PubMed ID: 1952960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophoretic analysis of the cytoplasmic and nuclear protein changes after induction of differentiation in WEHI-3B myelomonocytic leukemia cells.
    Cooper PC; Burgess AW
    J Cell Biochem; 1984; 25(3):161-82. PubMed ID: 6332817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of midazolam on the differentiation of murine myeloid leukemia cells.
    Mak NK; Szeto YY; Fung MC; Leung KN; Kwan SK
    Chemotherapy; 1997; 43(4):272-81. PubMed ID: 9209784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The production of differentiation autoinducing activity by WEHI-3B D+ leukemia cells.
    Kajigaya Y; Ikuta K; Sasaki H; Funabiki T; Koiso Y; Matsuyama S
    Exp Hematol; 1989 May; 17(4):368-73. PubMed ID: 2785052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bryostatin 1: a potential anti-leukemic agent for chronic myelomonocytic leukemia.
    Lilly M; Brown C; Pettit G; Kraft A
    Leukemia; 1991 Apr; 5(4):283-7. PubMed ID: 2027297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Membrane-bound tumour necrosis factor alpha: immunocytochemical and ultrastructural studies of human monocytes and monocytic cell line and its induction by tumour cells in vitro.
    Mytar B; Stachura J; Kielar B; Stec WJ; Zembala M
    Patol Pol; 1992; 43(2):51-4. PubMed ID: 1296176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic induction of the differentiation of WEHI-3B D+ myelomonocytic leukemia cells by retinoic acid and granulocyte colony-stimulating factor.
    Li J; Sartorelli AC
    Leuk Res; 1992; 16(6-7):571-6. PubMed ID: 1378916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergism of prostaglandin E2 plus TNF in induction of differentiation of human monocytoid leukemic U-937 cells.
    Hosoi T; Takeda K; Konno K
    Anticancer Res; 1989; 9(3):615-8. PubMed ID: 2548432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of biochanin A on the growth and differentiation of myeloid leukemia WEHI-3B (JCS) cells.
    Fung MC; Szeto YY; Leung KN; Wong-Leung YL; Mak NK
    Life Sci; 1997; 61(2):105-15. PubMed ID: 9217269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-inflammatory protein of Schistosoma japonicum directs the differentiation of the WEHI-3B JCS cells and mouse bone marrow cells to macrophages.
    Hu S; Yang L; Wu Z; Mak NK; Leung KN; Fung MC
    J Biomed Biotechnol; 2010; 2010():867368. PubMed ID: 20204135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor necrosis factor is partly responsible for the differentiation of mouse myeloid leukemia cells.
    Nakaya K; Nakajo S; Shimizu T; Hayashi Y; Nakamura Y
    Biochem Int; 1987 Dec; 15(6):1213-9. PubMed ID: 3440028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.